| Accession | ARO:3004630 |
| CARD Short Name | Mgen_parC_MXF |
| Definition | Mycoplasma genitalium exhibits multiple mutations in parC which confers resistance to Moxifloxacin. |
| AMR Gene Family | fluoroquinolone resistant parC |
| Drug Class | fluoroquinolone antibiotic |
| Resistance Mechanism | antibiotic target alteration |
| Classification | 11 ontology terms | Show + process or component of antibiotic biology or chemistry + mechanism of antibiotic resistance + antibiotic target alteration [Resistance Mechanism] + mutation conferring antibiotic resistance + determinant of antibiotic resistance + antibiotic resistant gene variant or mutant + antibiotic resistant DNA topoisomerase subunit + antibiotic molecule + fluoroquinolone resistant DNA topoisomerase + antibiotic resistant DNA topoisomerase subunit parC + fluoroquinolone antibiotic [Drug Class] |
| Parent Term(s) | 2 ontology terms | Show + confers_resistance_to_antibiotic moxifloxacin [Antibiotic] + fluoroquinolone resistant parC [AMR Gene Family] |
| Publications | Shimada Y, et al. 2010. Int. J. Antimicrob. Agents 36(3):255-8 Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance. (PMID 20580532) Gruson D, et al. 2005. Antimicrob Agents Chemother 49(3): 1190-1193. In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively. (PMID 15728924) Beeton ML, et al. 2009. J. Antimicrob. Chemother. 64(3):529-38 Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism. (PMID 19567408) Tagg KA, et al. 2013. J. Clin. Microbiol. 51(7):2245-9 Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium. (PMID 23658265) Hamasuna R, et al. 2018. PLoS ONE 13(6):e0198355 Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains. (PMID 29883482) |
Prevalence of Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin among the sequenced genomes, plasmids, and whole-genome shotgun assemblies available at NCBI or IslandViewer for 414 important pathogens (see methodological details and complete list of analyzed pathogens). Values reflect percentage of genomes, plasmids, genome islands, or whole-genome shotgun assemblies that have at least one hit to the AMR detection model. Default view includes percentages calculated based on Perfect plus Strict RGI hits. Select the checkbox to view percentages based on only Perfect matches to AMR reference sequences curated in CARD (note: this excludes resistance via mutation as references in protein variant models are often wild-type, sensitive sequences).
| Species | NCBI Chromosome | NCBI Plasmid | NCBI WGS | NCBI GI | GRDI-AMR2 |
|---|---|---|---|---|---|
| No prevalence data | |||||
Model Type: protein variant model
Model Definition: Protein Variant Models (PVM) perform a similar search as Protein Homolog Models (PHM), i.e. detect protein sequences based on their similarity to a curated reference sequence, but secondarily screen query sequences for curated sets of mutations to differentiate them from antibiotic susceptible wild-type alleles. PVMs are designed to detect AMR acquired via mutation of house-keeping genes or antibiotic targets, e.g. a mutated gyrase resistant to aminocoumarin antibiotics. PVMs include a protein reference sequence (often from antibiotic susceptible wild-type alleles), a curated bit-score cut-off, and mapped resistance variants. Mapped resistance variants may include any or all of single point mutations, insertions, or deletions curated from the scientific literature. A Strict RGI match has a BLASTP bit-score above the curated BLASTP cutoff value and contains at least one curated mutation from amongst the mapped resistance variants, while a Loose RGI match has a bit-score less than the curated BLASTP bit-score cut-off but still contains at least one curated mutation from amongst the mapped resistance variants.
Bit-score Cut-off (blastP): 1200
PubMed: mutation data hand curated from the scientific literature, evaluated as conferring resistance (R). CRyPTIC: mutation data acquired from the CRyPTIC catalog, evaluated as resistant (R), susceptible (S), or undetermined (U). ReSeqTB: mutation data acquired from the ReSeqTB catalog, evaluated as conferring resistance (Minimal, Moderate, High), not conferring resistance (None), or Indeterminate. WHO: mutation data acquired from the WHO 2023 catalog, evaluated as resistant (R), susceptible (S), or undetermined (U).| Mutation | Mutation type | PubMed |
|---|---|---|
| P62S | single resistance variant | PMID:29883482 |
| A66T | single resistance variant | PMID:29883482 |
| A67S | single resistance variant | PMID:29883482 |
| G81C | single resistance variant | PMID:15728924 |
| D82N | single resistance variant | PMID:19567408 |
| S83N | single resistance variant | PMID:29883482 |
| S83R | single resistance variant | PMID:20580532 |
| S83I | single resistance variant | PMID:15728924 |
| D87N | single resistance variant | PMID:15728924 |
| D87G | single resistance variant | PMID:15728924 |
| D87H | single resistance variant | PMID:20580532 |
| D87Y | single resistance variant | PMID:20580532 |
| V103I | single resistance variant | PMID:23658265 |
| A119V | single resistance variant | PMID:29883482 |
| Curator | Description | Most Recent Edit |
|---|